Prescription drug · ANDA
Diclofenac Sodium NDC 71335-0456
Diclofenac sodium 75 mg/1 · Tablet, Delayed release · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0456-0 | 71335045600 | 40 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-0)Marketed from Aug 24, 2009 | |
| 71335-0456-1 | 71335045601 | 28 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-1)Marketed from Aug 24, 2009 | |
| 71335-0456-2 | 71335045602 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-2)Marketed from Aug 24, 2009 | |
| 71335-0456-3 | 71335045603 | 20 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-3)Marketed from Aug 24, 2009 | |
| 71335-0456-4 | 71335045604 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-4)Marketed from Aug 24, 2009 | |
| 71335-0456-5 | 71335045605 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-5)Marketed from Aug 24, 2009 | |
| 71335-0456-6 | 71335045606 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-6)Marketed from Aug 24, 2009 | |
| 71335-0456-7 | 71335045607 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-7)Marketed from Aug 24, 2009 | |
| 71335-0456-8 | 71335045608 | 15 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-8)Marketed from Aug 24, 2009 | |
| 71335-0456-9 | 71335045609 | 14 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-0456-9)Marketed from Aug 24, 2009 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Diclofenac Sodium
- Generic name (nonproprietary)
- diclofenac sodium
- Active ingredients
- Diclofenac sodium — 75 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077863
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Prostaglandin Production (Physiologic effect)
- Identifiers
- Product ID 71335-0456_824033ce-a50b-4914-b0b9-b0005739555cSPL ID 824033ce-a50b-4914-b0b9-b0005739555cSPL set ID 487fa223-f4d9-4ab1-a5af-fb0d93f2bd0eRxCUI 855926UNII QTG126297Q
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335045600followed by a unit qualifier and the quantityPackage 71335-0456-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration and Perforation ). Diclofenac sodium delayed-release tablets are indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077863
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | NuCare Pharmaceuticals,Inc. | 66267-071 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Coupler LLC | 67046-1482 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Sportpharm LLC | 85766-010 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Asclemed USA, Inc. | 76420-670 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | PHOENIX RX LLC | 85509-1201 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Preferred Pharmaceuticals Inc. | 68788-8193 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | PD-Rx Pharmaceuticals, Inc. | 72789-578 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Rising Pharma Holdings, Inc. | 16571-201 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | American Health Packaging | 60687-658 |
| Diclofenac DRdiclofenac | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Advanced Rx of Tennessee, LLC | 80425-0056 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | Proficient Rx LP | 63187-012 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | BluePoint Laboratories | 68001-281 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | St. Mary's Medical Park Pharmacy | 60760-090 |
| Diclofenac Sodium | Diclofenac sodium 75 mg/1 | Tablet, Delayed releaseOral | A-S Medication Solutions | 50090-6924 |